Bank of America Lowers Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $547.00

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price lowered by Bank of America from $575.00 to $547.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an underperform rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently commented on the stock. Truist Financial dropped their […]